The COVID-19 variant NB.1.8.1, also known as 'Nimbus,' is linked to a rise in sore throat cases, prompting discussion among health professionals. Reports from countries like the UK and India indicate this variant may be responsible for a growing number of infections. Although its prevalence is increasing, particularly in the eastern Mediterranean and Southeast Asia, the WHO considers the public health risk low, affirming the effectiveness of current vaccines. Experts maintain that the Nimbus variant does not result in more severe illness compared to earlier variants.
The COVID-19 variant NB.1.8.1, nicknamed 'razor blade throat' COVID, primarily causes painful sore throats and has been identified in multiple countries.
While there has been a rise in cases, health experts indicate that the Nimbus variant does not cause more severe disease than previous variants.
Current vaccines remain effective against the Nimbus variant, as WHO classifies it as a 'variant under monitoring' with a low public health risk.
Despite the increase in cases, health authorities suggest that there is no major cause for concern regarding the Nimbus variant.
Collection
[
|
...
]